Biotech news continually updated from thousands of sources around the net.
1 hr ago | Barron's
For more than two years, Wall Street's love affair with drug makers has been fueled by the race to launch exciting new cancer drugs and oral therapies for hepatitis C. This weekend, Swiss drug maker Novartis got a big shot in the arm from a new drug that could be the biggest breakthrough in the treatment of heart failure in more than a decade.
3 hrs ago | Business Journal
I write a lot about how the bourbon industry is doing very well in recent years.
4 hrs ago | JD Supra
The U.S. Supreme Court's decisions in Molecular Pathology v. Myriad Genetics, Inc. and Mayo Collaborative Services v.
5 hrs ago | WTVR Richmond
The Ebola outbreak in West Africa is much worse than official figures show, and other countries are unintentionally making it harder to control, Centers for Disease Control and Prevention Director Dr. Tom Frieden told CNN on Tuesday.
6 hrs ago | Business Journal
Let's say the last time you were paying close attention to what's going on at local publicly traded biotech firms, it was the Friday before Memorial Day and you were headed to Cape Cod.
7 hrs ago | TheStreet.com
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
7 hrs ago | News Max
Johnson & Johnson , which set aside $2.5 billion last year to resolve claims that 8,000 of its artificial hips were defective, faces a new round of lawsuits over another line of hip implants blamed for poisoning patients.
11 hrs ago | West Australian
Instead, he has spent the last three days immersed in heart science in Barcelona.
11 hrs ago | GlobeNewswire
BioCryst Pharmaceuticals, Inc. today announced the presentation of trial results related to intravenous peramivir for the treatment of influenza at the Interscience Conference on Antimicrobial Agents & Chemotherapy in Washington, D.C., September 5-9, 2014.
Scott Spangler, principal data scientist for IBM Watson Innovations, demonstrates how its cognitive technology can display connections in scientific literature and drug information.
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today announced that it will present at the 18th International Colloquium on Lung and Airway Fibrosis to be held this September in Mont Tremblant, Quebec, Canada.
The director of the U.S. Centers for Disease Control and Prevention expressed confidence Monday in screening measures at the international airport in the Guinean capital Conakry to prevent the spread of Ebola.
CombiMatrix CFO Scott R. Burell bought 1,000 shares of the stock on the open market in a transaction that occurred on Wednesday, August 27th.
The National Institutes of Health announced Thursday that it is launching the safety trial on a vaccine developed by the agency's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline.
Eli Lilly and has earned an average recommendation of "Buy" from the twenty-two analysts that are presently covering the stock, Analyst Ratings Network.com reports .
A Chicago couple determined to raise awareness and much-needed funding for childhood cancer research embarked on an awe-inspiring 3,069-mile cross-country bicycle journey, taking off Sunday morning from Ocean Beach.
In America, one in 68 kids has autism, according to the Centers for Disease Control and Prevention.
Updated: Tue Sep 02, 2014 04:37 pm
Copyright © 2014 Topix LLC